A bonus episode featuring a conversation with top executives at Johnson & Johnson Diabetes Care Companies (parent company of Animas). John Wilson is the Worldwide Vice President, Insulin Delivery and Krishna Venugopalan is the Worldwide Director, Research & Development, Insulin Delivery. They talk to Stacey about the significance of this approval, about Animas’s agreement with Dexcom and what’s coming next as that company moves forward with the Share, G5 and G6 versions of their CGM.
Find out more about Moms’ Night Out
Please visit our Sponsors & Partners – they help make the show possible!
Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com)
Check out VIVI Cap to protect your insulin from extreme temperatures
Learn more about AG1 from Athletic Greens
Drive research that matters through the T1D Exchange
The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
Sign up for our newsletter here
Here’s where to find us:
Learn more about everything at our home page www.diabetes-connections.com
Reach out with questions or comments: info@diabetes-connections.com